Stock 600594 GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guizhou Yibai Pharmaceutical Co., Ltd.

Equities

600594

CNE000001H03

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-05 pm EDT 		5-day change 1st Jan Change
4.26 CNY +2.40% Intraday chart for Guizhou Yibai Pharmaceutical Co., Ltd. +2.40% -25.13%
Apr. 18 Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 YiBai Pharma to Repurchase Up to 40 Million Yuan Shares MT

Business Summary

GUIZHOU YIBAI PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the production and distribution of pharmaceuticals. The Company provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The company's products are applied in the treatment of cancer, cardiovascular and cerebrovascular, orthopedics, digestion, gynecology, children and breathing, among others. The Company mainly conducts its businesses within domestic markets.

Number of employees: 5,509

Sales per Business

CNY in Million2022Weight2023Weight Delta
Anti-tumor
43.7 %
1,273 46.5 % 1,232 43.7 % -3.20%
Other
19.3 %
404 14.8 % 544 19.3 % +34.67%
Medical
16.2 %
457 16.7 % 458 16.2 % +0.28%
Gynecological drugs
10.3 %
283 10.3 % 291 10.3 % +2.85%
Cardiovascular
10.0 %
313 11.4 % 283 10.0 % -9.56%
Other Business
0.4 %
6 0.2 % 12 0.4 % +108.34%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
2,735 100.0 % 2,821 100.0 % +3.12%

Managers

Managers TitleAgeSince
Ya Qi Dou CEO
 Chief Executive Officer 40 08-04-30
Xian Hong Jiang DFI
 Director of Finance/CFO 39 20-03-22
Zhi Wei Wang BRD
 Director/Board Member 54 11-02-20
Guang Xin Zhou IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Qi Ling Dou FOU
 Founder 64 95-05-31
Zhi Wei Wang BRD
 Director/Board Member 54 11-02-20
Ya Qi Dou CEO
 Chief Executive Officer 40 08-04-30
Wen Zong Peng BRD
 Director/Board Member 52 13-06-26
Tao Jiang CHM
 Chairman 44 21-05-12
Jian Pu BRD
 Director/Board Member 46 21-05-12
Jian Qiong Liang BRD
 Director/Board Member 42 19-09-16
Qin Song BRD
 Director/Board Member 68 23-06-29
Yi Song Chen BRD
 Director/Board Member 52 23-06-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 791,927,400 541,141,729 ( 68.33 %) 0 68.33 %

Shareholders

NameEquities%Valuation
Qi Ling Dou
23.42 %
185,457,636 23.42 % 122 M ¥
China Southern Asset Management Co., Ltd.
1.026 %
8,127,198 1.026 % 5 M ¥
China Asset Management Co., Ltd.
0.4590 %
3,635,215 0.4590 % 2 M ¥
GF Fund Management Co., Ltd.
0.2716 %
2,151,042 0.2716 % 1 M ¥
HuaAn Securities Co. Ltd. (Investment Management)
0.2690 %
2,130,000 0.2690 % 1 M ¥
Penghua Fund Management Co., Ltd.
0.1591 %
1,260,100 0.1591 % 828 163 ¥
Gfund Management Co., Ltd.
0.0767 %
607,200 0.0767 % 399 064 ¥
Wanjia Asset Management Co., Ltd.
0.0573 %
454,100 0.0573 % 298 444 ¥
CCB Principal Asset Management Co., Ltd.
0.0481 %
381,090 0.0481 % 250 460 ¥
Ya Qi Dou
0.0333 %
263,400 0.0333 % 173 112 ¥

Company contact information

Guizhou Yibai Pharmaceutical Co., Ltd.

No. 220-1 Baiyun Avenue Yunyan District

550008, Guiyang

+86 85 1847 05590

http://www.gzcci.com
address Guizhou Yibai Pharmaceutical Co., Ltd.(600594)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
GUIZHOU YIBAI PHARMACEUTICAL CO., LTD. Stock Guizhou Yibai Pharmaceutical Co., Ltd.
-25.13% 468M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 690B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.45% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.81% 235B
NOVARTIS AG Stock Novartis AG
+5.01% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.98% 195B
AMGEN INC. Stock Amgen Inc.
+3.98% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600594 Stock
  4. Company Guizhou Yibai Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW